YZR Capital
Investor profile
Venture capital
Also recorded as: YZR
Deals
23
distinct rounds
Companies
18
backed
Active span
2022–2026
5 yrs
Total round €
€132M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Antler2
- Arve Capital2
- Bayern Kapital2
- Heartfelt2
- Mustard Seed Maze2
- Triple Point Ventures2
- 10x Founders1
- 4growth VC1
- Albert Nieto1
- AlbionVC1
- Angel Invest Ventures1
- Apollo Health Ventures1
- APX1
- Arthur Mensch1
- Aviva Ventures1
- better ventures1
- Brandenburg Kapital1
- Calm Storm Ventures1
- Capacura1
- Cornelia Oelling1
- D11Z Ventures1
- Damian Zapłata1
- Daniel Zacharias1
- Dirk Freise1
- DN Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Biorce | Spain | 2 | €48M |
| Scan.com | UK | 2 | €14M |
| Scripta Therapeutics | UK | 1 | €10M |
| roclub | Germany | 1 | €10M |
| apoQlar | Germany | 2 | €10M |
| DaphOS | Austria | 1 | €5.0M |
| Clare&me | Germany | 2 | €4.7M |
| Esper Bionics | Ukraine | 1 | €4.7M |
| uP Patient | Poland | 1 | €4.6M |
| Doctor.One | Poland | 1 | €4.0M |
| Kalia Lab | Germany | 1 | €3.9M |
| Holi | Poland | 2 | €3.7M |
| dehaze | Germany | 1 | €3.2M |
| OpenHealth Technologies | Germany | 1 | €2.6M |
| deepeye | Germany | 1 | €2.5M |
| Mindsurance | Germany | 1 | €1.2M |
| Caire | Germany | 1 | €850k |
| IQONIC.AI | Germany | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Biorce | Series A | €44M | 2026-02 |
| Scan.com | Series A | €11M | 2023-04 |
| Scripta Therapeutics | Seed | €10M | 2025-11 |
| roclub | Series A | €10M | 2025-10 |
| apoQlar | Other | €10M | 2024-05 |
| DaphOS | Other | €5.0M | 2025-07 |
| Esper Bionics | Other | €4.7M | 2024-06 |
| uP Patient | Other | €4.6M | 2022-02 |
| Doctor.One | Seed | €4.0M | 2025-09 |
| Kalia Lab | Other | €3.9M | 2024-04 |